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Abstract
Background: Compartmentalization of HIV-1 between the genital tract and blood was noted in half of 57 women included
in 12 studies primarily using cell-free virus. To further understand differences between genital tract and blood viruses of
women with chronic HIV-1 infection cell-free and cell-associated virus populations were sequenced from these tissues,
reasoning that integrated viral DNA includes variants archived from earlier in infection, and provides a greater array of
genotypes for comparisons.
Methodology/Principal Findings: Multiple sequences from single-genome-amplification of HIV-1 RNA and DNA from the
genital tract and blood of each woman were compared in a cross-sectional study. Maximum likelihood phylogenies were
evaluated for evidence of compartmentalization using four statistical tests. Genital tract and blood HIV-1 appears
compartmentalized in 7/13 women by $2 statistical analyses. These subjects’ phylograms were characterized by low
diversity genital-specific viral clades interspersed between clades containing both genital and blood sequences. Many of the
genital-specific clades contained monotypic HIV-1 sequences. In 2/7 women, HIV-1 populations were significantly
compartmentalized across all four statistical tests; both had low diversity genital tract-only clades. Collapsing monotypic
variants into a single sequence diminished the prevalence and extent of compartmentalization. Viral sequences did not
demonstrate tissue-specific signature amino acid residues, differential immune selection, or co-receptor usage.
Conclusions/Significance: In women with chronic HIV-1 infection multiple identical sequences suggest proliferation of HIV-
1-infected cells, and low diversity tissue-specific phylogenetic clades are consistent with bursts of viral replication. These
monotypic and tissue-specific viruses provide statistical support for compartmentalization of HIV-1 between the female
genital tract and blood. However, the intermingling of these clades with clades comprised of both genital and blood
sequences and the absence of tissue-specific genetic features suggests compartmentalization between blood and genital
tract may be due to viral replication and proliferation of infected cells, and questions whether HIV-1 in the female genital
tract is distinct from blood.
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Introduction
Distinct genetic populations of HIV-1 in the genital tract
compared to blood have been reported in 170 men [1,2,3,4,5] and
57 women [6,7,8,9,10,11,12,13,14,15,16,17,18]. Physical parti-
tions, cellular membranes, inadequate penetration of antiretroviral
drugs into the genital tract [19,20] or localized inflammation
[7,8,9] are hypothesized to facilitate replication in the genital tract
independently from the blood, and allow evolution of HIV-1
genital tract variants that appear distinct from the blood [6,7,8].
The central role of the female genital tract in both sexual and
perinatal HIV-1 transmission underscores the importance of
understanding viral evolution within these tissues, which should
contribute to the development of effective treatments and
prevention strategies, including vaccines. While multiple reports
suggest that HIV-1 appears compartmentalized between the
genital tract and the blood of women [6,7,8,9,10,11,12,13,14,
15,16,17,18,21], we hypothesized that the absence of strict
physical barriers between the female genital tract and blood
would allow viruses to mix between these two tissues.
Studies reporting compartmentalization of viruses within the
female genital tract have often analyzed only cell-free viruses
[8,9,11,12,13,15,16,17], which, given the rapid turnover of HIV-
1, are derived primarily from recent cycles of replication. We
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7122expand on these studies by analyzing both cell-free HIV-1 RNA
and cell-associated HIV-1 DNA to sample both replicating and
archived viruses, respectively, in the blood and genital tract. Our
sequencing of single genome-amplifications of a relatively large
sampling of viruses from these two tissues allowed us to carefully
consider whether HIV-1 is compartmentalized between the genital
tract and blood of women.
Materials and Methods
Study design
A cross-sectional study of chronically HIV-1 infected women
compared viral populations in each woman’s genital tract to her
blood. Viral sequences were derived by single genome amplifica-
tion (SGA). To control for variations in HIV-1 shedding
throughout the menstrual cycle subjects’ study visits were
conducted during the luteal phase of their cycle [22]. Demo-
graphic, medical, and reproductive health information was
collected from medical records. The study was conducted at
University of Washington, following procedures approved by the
Institutional Review Board, and after subjects’ written consent.
Study eligibility was not limited by use of antiretroviral drugs.
Participants were classified into one of three categories according
to antiretroviral treatment (ART) and plasma viral load at the time
specimens were collected: ‘‘effective ART’’, when virus replication
was suppressed to ,50 copies/mL; ‘‘failing ART’’, defined as
receiving ART, but with plasma HIV-1 RNA .400 c/mL; and
‘‘no ART’’, when not receiving ART.
Ethics Statement
The study was conducted at University of Washington,
following procedures approved by the University of Washington
Institutional Review Board. All study participants provided written
informed consent.
Specimen processing
Blood plasma and PBMC were separated using Accuspin
TM
tubes (Sigma-Aldrich, St. Louis, MO). Cells were counted using a
Beckman Coulter Z1 Coulter Particle Counter (Brea, CA) or
hemocytometer. The cell pellet and plasma fraction were stored at
280uC until nucleic acids were extracted.
Cervical secretions were obtained by placing three filter paper
wicks (Sno-Strip
TM, Chauvin Pharmaceuticals, Romford, Essex,
UK) into the cervical os. After absorption of ,24 uL of fluid the
strips were visually inspected for blood contamination and placed
in guanidinium isothiocyanate extraction solution (4 M; Sigma-
Aldrich) [22]. After application of lidocaine spray, a single-punch
biopsy of the cervix adjacent to the os was obtained using Baby
Tischler Cervical Biopsy Forceps (Howard Medical Company,
Chicago, IL) and placed into RPMI. The cervical tissues were
snap-frozen in Optimal Cutting Temperature freezing medium
(Tissue-Tek, VWR, West Chester, PA) by floating in a cryomold
(Tissue-Tek) on top of 2-methyl-butane cooled by dry ice. Tissues
were stored at 280uC until sectioned for DNA extraction.
Quantification of HIV-1 RNA
Virions in 500 mL of plasma were concentrated by ultra-
centrifugation. Guanidinium isothiocyanate extraction solution (4
M; Sigma-Aldrich) was added to viral pellet. GeneAmplimer pAW
109 RNA plasmid (Applied Biosystems, Foster City, CA) was
added to plasma virus or 300 mL of cervical secretions in
guanidinium solution. Silica was used to extract nucleic acids
[23]. Extracted RNA was reverse transcribed and quantified in a
one-step RT-PCR real-time assay (Roche Diagnostics, Indiana-
polis, IN and ABI Prism 7700, Foster City, CA) as described
[24,25].
Quantification of cell-associated HIV-1 DNA
DNA was extracted from PBMC using the IsoQuick nucleic acid
extraction kit (Orca Research Inc., Bothell, WA). Cervical DNA
was isolated from 4 to 8 sections, each 20 mM thick, of the punch
biopsy tissue, using the Gentra DNA Purification System (Minnea-
polis, MN). Viral genome of extracted DNA and some cDNA
samples were quantified using limiting dilution PCR [26,27].
Sequencing of multiple HIV-1 RNA and DNA genomes by
single-genome-amplification (SGA)
The nucleic acids in 0.2–1 mL of plasma and 20–50 mLo f
genital secretions were extracted using either the Qiagen QIAamp
Viral RNA Mini-kit (Qiagen Inc., Valencia, CA) or when the viral
load was below the limit of detection (,50 copies/mL) using silica
with slight modifications [23]. Purified RNA was reverse
transcribed using Superscript II (Invitrogen, Carlsbad, CA) into
cDNA with BH2 primer for env [28].To control for amplification
of cell associated HIV-1 DNA in plasma and genital Sno-strip
samples, RNA extracted from specimens were pooled across
multiple subjects into a ‘‘no reverse transcriptase (RT)’’ control,
and PCR for HIV-1 env was conducted as described below. None
of these controls yielded amplicons, suggesting negligible DNA
contamination in plasma and Sno-strip specimens from these
subjects. Viral gene sequences corresponding to the C2-V5 region
of HIV-1 env were derived as previously described [24]. This
region of env was chosen for its genetic diversity and because it
amplifies in multiplexed end-point dilution PCR at a sensitivity
similar to regions encoding RT and PR [27].
Sequence analysis and phylogram construction
Sequences were assembled and checked for read errors and
hypermutation [27]. An all-inclusive phylogram was constructed
to verify that each sequence segregated only with others from the
identified participant. An evolutionary model was selected in
PAUP* version 4.0b10 using Modeltest version 3.7 and the Akaike
information criterion as previously described [27]. A phylogenetic
tree based on maximum likelihood estimation for each subject’s
sequences was generated using PAUP as previously described [24].
Evaluation of peripheral blood and genital tract
sequences for evidence of viral compartmentalization
The compartmental structure of viral sequences from each
subject was evaluated by four distinct statistical tests using either
tree- or distance-based parameters: (1) Slatkin and Maddison (SM)
evaluates variation from normalcy in the distribution of sequences
over a predicted tree structure using MacClade [7,29,30]; (2)
Hudson’s nearest neighbor (Snn) compares genetic distances
between sequences within and between tissues independent of
phylogeny [31]; (3) The Critchlow correlation coefficient rb
compares the number of nodes between sequences within and
between tissues; and (4) the Critchlow coefficient r compares tree-
based genetic distances within and between tissues [32]. The SM
test was further evaluated using 100 bootstrap replicate phylog-
enies [7,33]. The Snn and correlation coefficients were calculated
in HyPhy with 1,000 permutations between tissues to determine
statistical significance [34,35]. P-values of ,0.0125 were consid-
ered to be evidence of compartmentalization after applying a
Bonferroni correction. The topology of each phylogenetic tree was
also reviewed, with particular attention to genital tract or
peripheral blood specific clades.
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Divergence of each sequence from the MRCA and population
diversity (estimated as the average pair-wise genetic distances)
were calculated using PAUP* version 4.0b10 with the correspond-
ing evolutionary model. The mean diversity and divergence were
calculated for each subject’s anatomical sites (plasma RNA, PBMC
DNA, genital RNA, and genital DNA).
Analysis of amino acid variation in HIV-1 env
Non-synonymous and synonymous distances (dN and dS,
respectively) and dN/dS ratios were based on maximum likelihood
trees with codon substitution models (codeml, PAML version 3.15)
[36,37]. The NSsites Model 0 was used to estimate the dN/dS
ratio for a set of sequences. Evidence of positive selection is
indicated by a dN/dS score .1. Selection at amino acid sites was
also ascertained using codeml, but with NSsites model 8, by Bayes
empirical Bayes (BEB) analysis for positive selection with posterior
probability .95% [38].
Atypical amino acid residues in genital tract sequences compared
with peripheral blood sequences were evaluated using the aligned
protein sequences from the C2-V5 env region in the Viral
Epidemiology Signature Pattern Analysis program (http://www.
hiv.lanl.gov/content/hiv-db/P-vespa/vespa.html) [39]. Shannon
entropy scores [40] were calculated for each position in the protein
alignment using the Entropy2 program (http://hiv-web.lanl.gov/
content/hiv-db/ENTROPY/entropy.html).
The number of potential N-linked glycosylation sites in blood
and genital tract sequences was determined using the N-
GLYCOSITE program [41] (http://hiv-web.lanl.gov/content/
hiv-db/GLYCOSITE/glycosite.html). HIV-1 co-receptor usage
was predicted for the V3 region amino acid sequences using the
position-specific scoring X4/R5 and SI/NSI matrices (subtype B
sequences), and/or the presence of basic amino acids at V3 region
sites 11 or 25 (all sequences) [42] (http://indra.mullins.microbiol.
washington.edu/pssm/).
Statistical analysis
Confidence intervals for entropy, average dN/dS values, and
mean diversity values were calculated using JMP (JMP, SAS
Institute, Cary, NC). Viral divergence values, number of dN/dS
sites and entropy between sequence sources (plasma, PBMC,
cervical RNA, and cervical DNA) were compared using Wilcoxon
Rank Sums tests (JMP, Cary, NC). Diversity values were
calculated using the mean pair-wise distances for all sequence
comparisons from a tissue [43]. Agreement between tests, the SM,
Snn, and Critchlow correlations, was evaluated using GraphPad
software and expressed as a k2score (http://www.graphpad.com/
quickcalcs/CatMenu.cfm).
DNA sequences derived from biopsied cervical tissue could be
from infected genital tract cells or from cells circulating in blood
vessels within the cervical tissue. Pair-wise distances generated in
PAUP were used to identify whether the nearest neighbor to each
genital DNA sequence was another genital tract or a blood
sequence. For each patient, generalized estimating equations
(GEE) with an exchangeable correlation matrix was used to
calculate 95% confidence intervals for the proportion of pair-wise
comparisons where genital DNA sequences were nearest to other
genital RNA and/or DNA sequences using SAS v9.1 (Cary, NC).
Under the assumption of random matching, we calculated the
random probability (proportion) that any sequence would be
matched with a genital DNA or genital RNA sequence [(# genital
RNA + # genital DNA sequences)/(# total sequences per
patient)]. If the random proportion fell outside of the GEE-based
confidence intervals, we concluded there was statistically signifi-
cant evidence that genital DNA sequences were more likely from
the cervix rather than a contaminant from blood passing through
cervical blood vessels.
Nucleotide sequence accession numbers
The gene sequences determined in this study were deposited in
GenBank under accession numbers EF624488-EF625226.
Results
Analyses to determine compartmental structure of
genital and blood HIV-1 populations
Cross-sectional analyses of HIV-1 populations in the genital tract
and blood were conducted on thirteen subjects (Table 1). A median
of 50 sequences was derived by SGA from each participant
(Table 2). When the maximum likelihood phylograms from each
subject’s sequences were assessed for compartmentalization be-
tween genital and blood viruses the outcome varied across the four
assays. Compartmentalization of genital viruses from the blood was
detected byone ormore statistical testsin10/13 (77%),two ormore
in 7/13 (54%), three or more tests in 5/13 (38%), or by all four tests
in 2/13 (15%) subjects (Table 3). As would be suggested by the poor
concordance across these tests, the k2score for correlations
between the methods were low (0.09–0.40), except between the
related Critchlow coefficients, rb and r (k score=0.68).
Close inspection of the five subjects with statistical evidence of
compartmentalization by three or more tests revealed pairs and
small clades of genetically similar and/or monotypic (identical)
viruses from the genital tract and/or blood (Subjects 4, 5, 8, 9 and
13 in Figure 1–4), suggestive of a burst of viral replication or
proliferation of infected cells. To explore whether recent replication
or proliferation biased the statistical tests towards compartmental-
ization, identical sequences were collapsed to a single sequence and
reanalyzed for compartmentalization. All five subjects had at least
10 sequences remaining from both the genital tract and the blood
for this analysis. The re-assessment yielded significant p-values for
fewer subjects (Table 3), showing that identical sequences inflate
statistical measures of compartmentalization.
The three subjects with HIV-1 populations compartmentalized
by three or more tests (Subjects 5, 9 and 13 Figure 2–4) had clades
comprised of blood-only and genital- only sequences. The genital-
only clades in each case included HIV-1 variants with low
diversity, however, each subject also had one or more clades
containing both blood and genital variants. Thus, despite
statistically significant compartmentalization (Table 3), phylogram
topologies showed intermingling of a portion of these subjects’
genital and blood sequences (Figure 1–4).
Notably, across 11/13 subjects, phylogenetic clades with
variants of $5% genetic distance, suggestive of an evolving viral
lineage, included both genital and blood variants with the
exception of Subjects 5 and 9. No unique clinical signs or
laboratory parameters that might account for the genital tract
clades of viruses were consistently identified in these two women
(e.g. cervicitis, bacterial vaginosis, HSV shedding, elevation of
inflammatory cytokines in vaginal lavage; data not shown) [44].
Each woman had a low diversity genital-specific clade and a large
blood-specific clade of relatively high diversity that contributed to
the compartmentalization.
We recognize that cell-associated viral sequences derived from
genital specimens could potentially include sequences from blood
due to HIV-1 infected cells traversing through blood vessels in the
cervix. To evaluate this possibility we assumed that if genital cell-
associated sequences were actually from blood, their distribution
within the phylogram should mirror blood. Visual examination of
HIV-1 in Blood vs. Cervix
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sequences cluster in large part with other genital RNA or DNA
sequences (Figure 1–4). Notably, viral clades composed only of
cervical DNA sequences were observed in six subjects (Subjects 2,
4, 5, 8, 9 and 13, Figure 1–4); an unexpected pattern if HIV-1
DNA were derived from blood contamination. To further assess
the likelihood that HIV-1 DNA genital sequences originated in
genital tract, we evaluated the tissue origin of the nearest neighbor
to each cell-associated genital sequence in the maximum likelihood
phylograms of all 13 subjects. In this analysis the nearest neighbor
to genital tract DNA sequences were other genital sequences in a
median of 64% of the comparisons (range 30–93%) (Table 4). The
observation that in all but one woman (Subject 3) we studied, the
majority of genital DNA sequences group with other genital
sequences suggests these likely originate from genital tissues, while
the origin of cell-associated genital sequences that do not cluster
with other genital viruses is less certain.
Amino acid sequence signatures and non-synonymous/
synonymous (dN/dS) site changes
No signature amino acid residues were identified in HIV-1
sequences from the genital tract or peripheral blood of the 13
participants (data not shown). Sites undergoing positive selection
were found in all 13 subjects. However, none were associated with
compartmentalization of virus between the blood and genital tract
(Supplemental Table S1), nor were there significant differences in
the number of positively selected sites between genital tract and
blood (p=0.48 Wilcoxon Rank Sum Test).
N-linked glycosylation and compartmental structure
The number of potential N-linked glycosylation sites per
sequence was significantly greater (Kruskal Wallis test p,0.05)
in the blood of three (2, 3, and 9) and in the genital tract of two
women (8, 10; data not shown). Overall, no trend was noted for N-
linked glycosylation sites in genital compared to blood viruses
(p=0.59 Wilcoxon Rank Sum Test).
Predicted co-receptor usage
CCR5 was predicted to be the predominant co-receptor for virus in
all of the subjects studied. HIV-1 viruses from three women were also
predicted to use the CXCR4 co-receptor, including viruses from both
the genital tract and peripheral blood. The CCR5- and CXCR4-
using viruses clustered separately in phylogenetic trees (Subjects 2, 4
and 12, Figure 1 and 3); but were not restricted to the blood or genital
tract and therefore did not appear to be compartmentalized.
Table 2. The Number of Sequences Generated from Each
Tissue examined in HIV-1 Infected Subjects.
Treatment
status Number of sequences analyzed
Subject ID PBMC Plasma Cervical DNA Cervical RNA
ART 1 18 3 14 6
23 3 0 1 3 6
‘‘Failing’’ ART 3 44 13 12 0
44 0 1 0 1 1 5
5 6 12 10 0
61 6 1 0 1 0 1 1
No ART 7 30 10 17 1
84 1 1 7 8 8
91 4 1 1 1 3 0
10 24 13 10 0
11 30 9 13 9
12 36 9 9 14
13 19 11 10 0
Notes: Treatment status defined by whether receiving ART at time of study, and
if so whether ART was ‘‘effective’’, defined by plasma levels ,50 HIV-1 RNA
copies/mL, or ‘‘failing’’ defined as plasma HIV-1 RNA values of .400 c/mL after
the initial 6 months of therapy.
doi:10.1371/journal.pone.0007122.t002
Table 1. Clinical parameters of study participants.
Treatment
Status Subject
Years Post HIV-1
Diagnosis
Mode of HIV-1
Acquisition Current ART CD4 Cells/mL CD4%
Plasma HIV-1
RNA c/mL
Cervical HIV-
1 RNA c/mL
ART 1 12 Sexual 3TC, TDF, EFV 290 20 ,50 ,600
a
2 9 Sexual 3TC, d4T, NFV 30 3 ,50 ,600
a
‘‘Failing’’ ART 3 4 Sexual 3TC, ZDV, EFV, NFV 280 32 35,000 1,500
4 11 IDU/Sexual 3TC, d4T, EFV 160 19 6,000 2,100
5 18 Sexual 3TC,ABC, NVP ND ND 16,700 ,600
6 10 Sexual FTC, TDF, LPV/r 467 29 69,000 7,800
No ART 7 2 Sexual None 640 38 11,000 1,500
8 16 IDU/Sexual None 460 21 16,000 18,000
9 8 Sexual None 909 10 100 15,000
10 8 Sexual None 366 23 50,000 ,600
11 1 Sexual None 667 34 3,000 2,800
12 8 Sexual None 386 21 277,000 77,000
13 1 Sexual None 679 46 17,000 ,600
Notes: Treatment status defined by whether receiving ART, and if so whether ART was ‘‘effective’’ with plasma levels ,50 copies/mL, or ‘‘failing’’ defined as plasma HIV-
1 RNA values of .400 c/mL after the initial 6 months of ART. FTC=Emtricitabine, 3TC=Lamivudine, d4T=Stavudine, ZDV=Zidovudine, EFV=Efavirenz,
TDF=Tenofovir, LPV/r=Lopinavir/ritonavir, NFV=Nelfinavir, NVP=Nevirapine. IDU=Intravenous Drug Use, No ART=not receiving ARV, ND=No data.
aLimiting dilution PCR estimated HIV-1 RNA in these specimens between 150-35,000 copies/mL [26].
doi:10.1371/journal.pone.0007122.t001
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HIV-1 env sequences were compartmentalized between the
genital tract and blood in half the women by two or more
statistical analyses. However, subjects’ HIV-1 was rarely classified
as compartmentalized by all four analyses, as indicated by
moderate concordance values. Our findings demonstrate that
the statistical algorithm used to evaluate the distribution of tissue-
specific sequences within a phylogram affects the outcome.,
consistent with a previous study comparing statistical methods to
evaluate compartmentalization of HIV-1 between the female
genital tract and blood [35]. Of note, visual examination of the
phylograms revealed clusters of monotypic and low-diversity
variants interspersed across the phylograms of all subjects with
compartmentalization by two or more tests. These tissue-specific
monotypic and low diversity clusters impacted the statistical tests
as shown by analyses conducted after collapsing monotypic
variants into a single sequence in most if not all the subjects.
Phylogenetic analyses found tissue-specific clades with strong
bootstrap support in half of the participants. However, in all but
two women small clades of viruses comprised of blood or genital
tract sequences intermingled in the phylograms. Across the
subjects, each genital clade with .70% bootstrap support includes
viruses with little genetic diversity suggestive of a burst of viral
replication similar to that observed for viruses from macaque
cervices [45] and human spleens [46,47]. Given that the diameter
of cervical specimens measured ,3mm, and that sequential tissue
sections were cut with a microtome for analysis, it is possible that
the HIV-1 DNA sequences derived from these tissues came from
adjacent or nearby cells. Genital secretions were similarly collected
only from one region of the cervical os. Both sampling strategies
could result in clades of monotypic or low diversity variants,
derived by single-genome sequencing, due to sampling limited
regions of the female genital tract where viruses are replicating.
However, monotypic viruses may not be solely due to replicating
viruses within a discrete area of tissue. When we biopsied multiple
regions of the cervix monotypic viruses were observed across the
cervix, and to a lesser extent in the blood [24]. Similarly, others’
have detected monotypic and low diversity HIV-1 env from
cervicovaginal lavages (CVL), which should sample the entire
cervical and vaginal surfaces, and presumably represent the most
fit variant [11,15,18,48]. Our detection of monotypic variants in
PBMC and blood plasma, which mix as the blood circulates,
suggests the possibility of a systemic phenomenon. We hypothesize
that monotypic viral variants may be from clonal expansion of
HIV-1 infected cells, that when activated produce virions with
identical genomes, as we [24,27] and others [7,49] have previously
observed.
Table 3. Evaluation of HIV-1 env for compartmentalization between the genital tract and blood using correlation coefficients,
Slatkin-Maddison, and Nearest-Neighbor Models.
Treatment Status Subject ID Blood and Genital Tract (RNA and DNA) Evaluated
# of tests (+) for compartment-
alization of HIV-1, with and without
combining monotypic sequences
rb p-value
a r p-value
a Snn
b p-values SM
c p-values
‘‘Effective’’ ART 1 ,0.102 ,0.049 0.011* 0.248 1
2 ,0.096 ,0.008* 0.015 0.025 1
‘‘Failing’’ ART 3 ,0.145 ,0.665 0.022 1.000 0
4 ,0.005* ,0.001* 0.005* 0.014 3
4
d ,0.041 ,0.012* 0.067 0.492 1
d
5 ,0.001* ,0.001* ,0.001* ,0.001* 4
6 ,0.789 ,0.522 0.011* 0.047 1
No ART 7 ,0.986 ,0.515 0.062 0.045 0
8 ,0.009* ,0.001* 0.023 0.009* 3
8
d ,0.106 ,0.001* 0.285 0.026 1
d
9 ,0.035 ,0.001* ,0.001* ,0.001* 3
9
d ,0.143 ,0.001* ,0.001* 0.037 2
d
10 ,0.106 ,0.148 0.001* ,0.001* 2
10
d ,0.011* ,0.011* 0.009* 0.002* 4
11 ,0.133 ,0.016 0.098 0.192 0
12 ,0.336 ,0.036 ,0.001* 0.002* 2
13 ,0.001* ,0.001* 0.010* 0.002* 4
13
d ,0.002* ,0.005* ,0.001* 0.220 3
d
Total subjects # (%) with com-
partmentalization of genital and
blood HIV-1 without collapsing
4 (31%) 6 (46%) 8 (62%) 6 (46%)
Notes: Treatment status defined by whether receiving ART, and if so whether ART was ‘‘effective’’, defined by plasma levels ,50 copies/mL, or ‘‘failing’’ defined as
plasma HIV-1 RNA values of .400 c/mL after the initial 6 months of therapy.
a–cViral compartmentalization assessed by Critchlow correlation coefficients (rb and r) [32], the nearest neighbor (Snn) [31] and Slatkin and Maddison (SM) [29].
dEvaluation of HIV-1 env compartmentalization between the genital tract and blood with identical sequences collapsed into a single sequence.
*Values p,0.0125 are considered significant after a Bonferroni correction for multiple comparisons.
doi:10.1371/journal.pone.0007122.t003
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from additional comparisons of the HIV-1 env populations from
uterine cervix and blood. Across our subjects we did not observe
tissue-specific signature amino acid residues, differential co-
receptor usage, or evidence for differential immune selection (as
measured by the patterns of non-synonymous site mutations) in
either genital tract or blood viruses. Viral population entropy and
diversity are also comparable in the genital tract and peripheral
blood of subjects we and others [10,15] have studied, which
suggests similar immune pressures or mixing of viruses between
these two tissues. The detection of viruses predicted to use
CXCR4 (X4) co-receptor in both genital tract and blood viruses of
our and others’ subjects [15] suggests that X4 variants co-evolve or
mix between the genital tract and blood, and importantly shows
that similar to men [1,50] X4 variants are not excluded from the
genital tract of women.
Taken together, our data suggest that when statistical analyses
of HIV-1 detect compartmentalization of genital tract and blood
viruses in cross-sectional studies it is often due to low diversity or
monotypic clusters, typical of a burst of replication or proliferation
Figure 1. Maximum likelihood phylogenetic analyses of HIV-1 sequences corresponding to the C2-V5 region of env. Phylograms of
blood and genital tract RNA and DNA sequences, derived by single-genome-amplification, are shown. Mixing of genital tract and blood sequences
was noted in phylograms of most subjects. Subjects 1 and 2 were studied during effective ART (,50 copies/mL). Subjects 3 and 4 were studied
during ‘‘failing’’ (.400 copies/mL) ART. HIV-1 sequences from plasma (gray stars); PBMC (gray circles), cell-free cervical RNA (black stars) and cell-
associated cervical DNA (black circles) are shown. Sequences that were predicted to encode X4-tropic virus are indicated with brackets. Bootstrap
values of .70% are indicated in each tree. Phylograms were rooted using representative sequences, indicated with the letter B, for the corresponding
subtype from GenBank (Clade B: B.US.83.RF, B.US.90.WEAU160, B.FR.83.HXB2, B.US.86.JRFL). The scale bar (horizontal line) indicates the horizontal
branch length corresponding to 1 substitution per 100 sites.
doi:10.1371/journal.pone.0007122.g001
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arrangement of genital and blood clades across the phylograms of
most subjects we studied questions whether the genital population
in each woman is distinct from viral population in her blood.
Across the literature, compartmentalization of HIV-1 within the
genital tract of women by statistical measures and detection of
discordant patterns of drug-resistance has been interpreted as
evolution of independent viral populations within the genital tract
[7,9,11,12,13,15,17]. Often these data were from cross-sectional
studies of cell-free viruses obtained from plasma and CVL from
women with ongoing viral replication, which suggests that unique
variants could predominant in the tissues for a period of time
[8,9,11,12,13,15,16,17,48].
Previous studies eliminated identical sequences from the analysis
[7,17] or evaluated only sequences with $0.3% genetic diversity [11]
andstillfoundmarkedcompartmentalization.Nevertheless,theHIV-
1 env sequences analyzed were often low diversity (,1%) cell-free
v i r u st h a ti sc o n s i s t e n tw i t hr e c e n tr o u n d so fv i r a lr e p l i c a t i o n[ 1 1 , 1 5 ] ,
which we contend biases analyses of compartmental structure.
Longitudinal analyses corroborate our contention that sampling sites
of replicating viruses or proliferating cells with provirus may bias
towards compartmentalization. An analysis that includes sequences
Figure 2. Maximum likelihood phylogenetic analyses of HIV-1 sequences corresponding to the C2-V5 region of env. Phylograms of
blood and genital tract RNA and DNA sequences, derived by single-genome-amplification, are shown. Mixing of genital tract and blood sequences
was noted in phylograms of most subjects. Subjects 5 and 6 were studied during ‘‘failing’’ (.400 copies/mL) ART. Subjects 7 and 8 were studied while
not receiving ART. HIV-1 sequences from plasma (gray stars); PBMC (gray circles), cell-free cervical RNA (black stars) and cell-associated cervical DNA
(black circles) are shown. Bootstrap values of .70% are indicated in each tree. Phylograms were rooted using representative sequences, indicated
with the letter B, for the corresponding subtype from GenBank (Clade B: B.US.83.RF, B.US.90.WEAU160, B.FR.83.HXB2, B.US.86.JRFL). The scale bar
(horizontal line) indicates the horizontal branch length corresponding to 1 substitution per 100 sites.
doi:10.1371/journal.pone.0007122.g002
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from three women, found the HIV-1 env sequences clustered by the
sampling time as well as tissue type [7]. Therefore, statistical models
used to compare HIV-1 populations between tissues may need to
account for the effects of viruses from recent replication or
proliferation of cells containing HIV-1 provirus.
Two longitudinal studies of drug resistance mutations in genital
tract secretions and blood detected mutational discordance from
one study visit that resolved at the next study visit [12,51]. While
these observations support mixing of viruses between tissues over
time, we acknowledge that mutants could be selected in parallel.
Others have noted that sequences from replicating viruses can
Figure 3. Maximum likelihood phylogenetic analyses of HIV-1 sequences corresponding to the C2-V5 region of env. Phylograms of
blood and genital tract RNA and DNA sequences, derived by single-genome-amplification are shown. Mixing of genital tract and blood sequences
was noted in phylograms of most subjects. Subjects 9, 10, 11, and 12 were studied while not receiving ART. HIV-1 sequences from plasma (gray stars);
PBMC (gray circles), cell-free cervical RNA (black stars) and cell-associated cervical DNA (black circles) are shown. Sequences that were predictedt o
encode X4-tropic virus are indicated with brackets. Bootstrap values of .70% are indicated in each tree. Phylograms were rooted using
representative sequences, indicated with the letter B or A, for the corresponding subtype from GenBank (Clade B: B.US.83.RF, B.US.90.WEAU160,
B.FR.83.HXB2, B.US.86.JRFL; Clade A1 A1.KE.93.Q23-17, A1.SE.94.SE7253, A1.UG.92.92UG037, A1.UG.85.U455). The scale bar (horizontal line) indicates
the horizontal branch length corresponding to 1 substitution per 100 sites.
doi:10.1371/journal.pone.0007122.g003
HIV-1 in Blood vs. Cervix
PLoS ONE | www.plosone.org 8 September 2009 | Volume 4 | Issue 9 | e7122predominate and obscure previously selected viral variants
[7,48,52], raising the question whether the momentary snapshot
of virus populations in cross-sectional analyses persists over time.
A potential difference between our study and those focused on
cell-free virions centers on the observation that approximately
33% of 311 women [8] do not shed HIV-1 from the genital tract
when virions are detectable in the plasma. In our study genital cell-
associated viruses were characterized even in the absence of
detectable cell-free virus. The origin of virions shed from the
genital tract is unclear. Potentially, the virus shed into the vagina
may be derived from a subset of resident genital cells or come from
lymphocytes and/or macrophages that migrate into the genital
tract in response to an infectious or other antigenic stimulus. Our
observation that HIV-1 RNA sequences from the cervical
secretions (RNA amplified from 8 of 13 subjects) clustered with
sequences amplified from the cervical DNA supports the
hypothesis that genital tract virions come from cells that were
sampled in genital biopsy tissue. Consistent with this phylogenic
clustering of genital RNA and DNA is an increase in tissue-specific
compartmentalization (data not shown). However, genital virions
may also have resulted from plasma transudates or bleeding, as a
few genital RNA sequences cluster with plasma sequences in
phylograms.
A limitation of our study is the uncertainty that genital HIV-1
DNA and RNA indeed originate from the genital tract, and are
not due to blood contamination of the cervical biopsies or Sno-
strip samples. Several experimental controls and analyses suggest
that the majority of sequences we derived from the genital tract
were likely from in situ viruses and not blood contaminates similar
to others’ observations [10,12,53]. First, blood contamination of
Sno-strips (slightly pink tinged) with cervical secretions was noted
in only 3/13 subjects, including Subject 9 who had compartmen-
talization of genital tract viruses in three of the four statistical tests
and the least ‘‘mixing’’ between blood and genital sequences in the
phylograms across all the study participants. Others have reported
that genital viral loads tend to be stable over the menstrual cycle
and that blood contamination contributes ,1% of the genital tract
viral load [9,22]; further suggesting that pink tinged Sno-strip
samples are not substantially contaminated with HIV-1 from the
blood. Second, the absence of template amplification in our ‘‘no
reverse transcriptase controls’’ performed using nucleic acids
extracted from genital secretions, suggests that HIV-1 DNA does
not appreciably contaminate Sno-strip specimens and masquerade
as viral RNA. Third, while we cannot definitely exclude the
possibility that viral sequences derived from DNA extracts of
cervical tissue are free of HIV-1-infected blood cells traversing
through the tissue, two observations indicate that sequences
derived from genital DNA likely originated from viral replication
in the genital tract: Phylogenetic clustering of genital sequences
have strong bootstrap support for viral clades composed only of
cervical DNA sequences; and the nearest neighbor sequence to the
majority of genital DNA is another genital tract sequence even in
instances where blood sequences outnumbered genital sequences.
In summary, our analyses of viral sequences from the blood and
genital tract of women with chronic HIV-1 infection suggest that
the multiple clusters of genetically similar and monotypic viruses,
particularly from the cervix, are likely from recent viral replication
or proliferation of cells with provirus, respectively. Statistical tests
used to assess virus compartmentalization appear biased by these
tissue-specific low-diversity viruses over the intermingling of blood
and genital clades evident in phylograms. If our hypothesis is
correct, then few if any significant barriers exist to the flow of
HIV-1 between the female genital tract and blood, and unique
genital tract viral lineages should not evolve and persist over time,
which is a hallmark of a viral compartment [54]. Longitudinal
studies are warranted to further define HIV-1 evolution in the
female genital tract; and to further investigate whether the
perception that female genital tract HIV-1 evolves separately
from blood is mistaken.
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Figure 4. Maximum likelihood phylogenetic analyses of HIV-1
sequences corresponding to the C2-V5 region of env.
Phylograms of blood and genital tract RNA and DNA sequences,
derived by single-genome-amplification are shown. Mixing of genital
tract and blood sequences were also noted in the phylogram of
Subject 13 who was studied while not receiving ART. HIV-1 sequences
from plasma (gray stars); PBMC (gray circles), cell-free cervical RNA
(black stars) and cell-associated cervical DNA (black circles) are shown.
Bootstrap values of .70% are indicated in each tree. Phylograms
were rooted using representative sequences, indicated with the letter
B, for the corresponding subtype from GenBank (Clade B: B.US.83.RF,
B.US.90.WEAU160, B.FR.83.HXB2, B.US.86.JRFL). The scale bar (horizontal
line) indicates the horizontal branch length corresponding to 1 substitution
per 100 sites.
doi:10.1371/journal.pone.0007122.g004
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